Anemia and long-term outcome in adjuvant and neoadjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: The Freiburg experience (1989-2002)

Table 7 Anemia and patient characteristics.

	Hb decreaseduring RTn (%)	P value
Age
≤ 621yr	42 (42.9)	0.31
> 621yr	32 (35.6)
Stage
II	18 (30.0)	0.07
III	56 (43.8)
Other serious diagnoses
No	38 (35.2)	0.17
Yes	36 (45.0)
BMI
≤ 24.22	44 (50.0)	0.03
> 24.22	18 (26.5)
Radiochemotherapy
Postoperative	56 (35.0)	0.03
Preoperative	18 (64.3)
Surgical Resection
LAR	42 (38.2)	0.96
APR	28 (37.8)
R status
R 0	24 (30.8)	0.04
R 1/2	10 (55.6)
Side effects
RTOG 0	8 (80.0)	0.27
RTOG I / II	62 (38.8)
RTOG III / IV	4 (22.2)

Results of chi-square test.

¹Median age,

²median BMI (body mass index).